New antibiotic may replace standard infection prevention in blood cancer patients
NCT ID NCT07616635
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether fosfomycin, an older antibiotic, works as well as ciprofloxacin for preventing serious infections in people with blood cancers like leukemia or those receiving a stem cell transplant. 177 adults from 11 Spanish hospitals took part. The main goal was to see how many developed fever with low white blood cell counts. The results could offer a safer alternative to current prevention methods.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LEUKEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hospital Universitario Central de Asturias
Oviedo, Principality of Asturias, 33011, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could muscle loss predict blood cancer outcomes?
- Could a platelet-boosting drug shorten recovery after stem cell transplants?
- Could bone marrow from deceased donors cure blood cancers?
- New dashboard aims to make leukemia trials more inclusive
- Gene mapping of childhood blood cancers could unlock personalized treatments
- New stem cell processing method offers hope for patients without a perfect donor match